The clinical time-course of experimental autoimmune uveoretinitis using topical endoscopic fundal imaging with histologic and cellular infiltrate correlation.
about
Tumour necrosis factor-mediated macrophage activation in the target organ is critical for clinical manifestation of uveitisThe role of lipoprotein-associated phospholipase A2 in a murine model of experimental autoimmune uveoretinitisNuclear receptor NR4A2 orchestrates Th17 cell-mediated autoimmune inflammation via IL-21 signallingAssessment and in vivo scoring of murine experimental autoimmune uveoretinitis using optical coherence tomographyIn vivo multi-modal imaging of experimental autoimmune uveoretinitis in transgenic reporter mice reveals the dynamic nature of inflammatory changes during disease progression.Tissue-resident exhausted effector memory CD8+ T cells accumulate in the retina during chronic experimental autoimmune uveoretinitis.SOCS3 deletion in T lymphocytes suppresses development of chronic ocular inflammation via upregulation of CTLA-4 and expansion of regulatory T cells.Road to fulfilment: taming the immune response to restore vision.Autoimmune and autoinflammatory mechanisms in uveitis.Use of optical coherence tomography and electroretinography to evaluate retinal pathology in a mouse model of autoimmune uveitis.Comparative analysis of induced vs. spontaneous models of autoimmune uveitis targeting the interphotoreceptor retinoid binding protein.Glucocorticoid-resistant Th17 cells are selectively attenuated by cyclosporine A.A novel pathogenic RBP-3 peptide reveals epitope spreading in persistent experimental autoimmune uveoretinitis.S100B Up-Regulates Macrophage Production of IL1β and CCL22 and Influences Severity of Retinal InflammationDual Function of the IRF8 Transcription Factor in Autoimmune Uveitis: Loss of IRF8 in T Cells Exacerbates Uveitis, Whereas Irf8 Deletion in the Retina Confers ProtectionThe Microbiota Determines Susceptibility to Experimental Autoimmune UveoretinitisA novel bispecific molecule delivered by recombinant AAV2 suppresses ocular inflammation and choroidal neovascularizationRole of the retinal vascular endothelial cell in ocular diseaseImaging Retinal Vascular Changes in the Mouse Model of Oxygen-Induced Retinopathy.Therapeutic dosing of fingolimod (FTY720) prevents cell infiltration, rapidly suppresses ocular inflammation, and maintains the blood-ocular barrier.An anti-TNF-α antibody mimetic to treat ocular inflammation.Migration, integration and maturation of photoreceptor precursors following transplantation in the mouse retinaGene therapy for noninfectious uveitis.Doyne lecture 2016: intraocular health and the many faces of inflammation.A portable, contact animal fundus imaging system based on Rol's GRIN lenses.Oral delivery of ACE2/Ang-(1-7) bioencapsulated in plant cells protects against experimental uveitis and autoimmune uveoretinitis.TNFR1 signalling is a critical checkpoint for developing macrophages that control of T-cell proliferation.Systemic and local anti-C5 therapy reduces the disease severity in experimental autoimmune uveoretinitis.Augmenting Endogenous Levels of Retinal Annexin A1 Suppresses Uveitis in Mice.Pharmacological Inhibition of Bromodomain Proteins Suppresses Retinal Inflammatory Disease and Downregulates Retinal Th17 Cells.Persistence of IL-2 expressing Th17 cells in healthy humans and experimental autoimmune uveitis.Comparison of Aqueous and Vitreous Lymphocyte Populations From Two Rat Models of Experimental Uveitis.
P2860
Q24633598-6E4393E7-1B58-4C82-969C-54CB260AE868Q27310393-3B66E9EB-133B-4FC0-84A3-1F107918ECA6Q27314385-5753F2AE-28F4-4002-B7A8-BC71F3EF62DBQ27321413-BB24AD84-26C6-4D6A-9F3E-DE8B1100F2B2Q30620955-CE3FA917-FBA6-4AD0-BE38-FE81ABD4B153Q33563989-21051062-54E0-4521-88B1-349884148C73Q33697768-6F51F8E7-B015-442F-9F09-88C5820F850EQ34259510-C38F71BD-0722-4D27-AABC-8EE73C526564Q34294964-C84F247C-22AB-4A75-8241-F59552648DF4Q34731124-ABEF93C0-3CCC-476F-A867-62B3597F07F6Q34981390-3C5199E9-B7F1-41D3-9A3F-2051B157B73CQ35280211-B50D5742-C1B4-44BC-9050-D657782C8B1AQ35685588-948EA862-7966-4742-8C93-908ADF4D93C0Q35708432-5931FEFA-B9A6-4392-9EE5-954A3043610FQ35931594-5C32876D-5F3B-42F5-8A54-040D8FA18BC8Q36050092-ACA4E934-7FB8-492B-97D9-32CA02434E00Q36319263-EBF4D251-8E58-4EFA-802E-19416198F47AQ36919959-DD488ABF-D74E-49D5-AA70-0EB7650B8450Q37149366-D08B196C-D531-4626-9449-1445B6617082Q37229011-F8193683-6892-4FC7-B10B-D2F475060A70Q37428259-C80886A4-AF62-4BA6-B5ED-1F52383ED435Q37718849-2FEBABA8-0909-4F34-8CCA-4396699C3B0AQ38060848-9B0A185E-E707-4ABA-9FD9-E44B815320FBQ38956279-0AE63E64-1F07-4E3C-9EBF-3462880ADC81Q40005614-ED5D3CBA-AB32-49C5-9D55-F6B44F0408AAQ40609980-25FAD818-33CF-4ABE-A4E4-2ED8AC63C645Q43046346-3DB0465E-0733-44E4-AA78-7BC23A3BCBAFQ43225419-CCA49DC4-3042-4491-A867-552AB0E03B15Q43270658-210F424D-722F-4BD9-BAED-FDB6A23AA9F1Q48105347-93B23A0E-DA26-4860-B505-E8F482445EA6Q50993290-019B8F1A-DA47-4472-BECF-78969FA580F7Q55262078-65C231E7-FB59-4C15-9282-28408E9B8F84
P2860
The clinical time-course of experimental autoimmune uveoretinitis using topical endoscopic fundal imaging with histologic and cellular infiltrate correlation.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
The clinical time-course of ex ...... llular infiltrate correlation.
@en
The clinical time-course of ex ...... llular infiltrate correlation.
@nl
type
label
The clinical time-course of ex ...... llular infiltrate correlation.
@en
The clinical time-course of ex ...... llular infiltrate correlation.
@nl
prefLabel
The clinical time-course of ex ...... llular infiltrate correlation.
@en
The clinical time-course of ex ...... llular infiltrate correlation.
@nl
P2093
P356
P1476
The clinical time-course of ex ...... llular infiltrate correlation.
@en
P2093
Andrew D Dick
Ben J E Raveney
David A Copland
Lindsay B Nicholson
Michael S Wertheim
W John Armitage
P304
P356
10.1167/IOVS.08-2348
P407
P577
2008-08-29T00:00:00Z